Search - tctmd.com

March 25, 2025

News Daily News

Slight Uptick in Mortality With TAVI in Recent Years: TVT Registry

October 18, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

September 16, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

May 06, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

February 23, 2024

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

July 27, 2023

News Daily News

The More Tweaks Made to PMA-Approved Devices, the More Likely a Recall

April 13, 2023

News Daily News

First-Ever Cardiac Surgery Trial in Women Poised to Launch: ROMA-Women

Shelley Wood

April 07, 2023

News Features

ChatGPT et al? Not So Fast, Say Journal Editors

Yael L. Maxwell

April 05, 2023

News Daily News

RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads

Todd Neale

January 19, 2023

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

October 28, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

September 23, 2022

News Conference News TCT 2022

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

September 16, 2022

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

August 23, 2022

News Daily News

Postmarketing Studies of CV Devices Still Lacking in the US

March 17, 2022

News Daily News

Penumbra’s JET 7 Recall: A Kick Start to Change?

December 01, 2021

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

September 30, 2021

News Daily News

VASCADE Closure Device: FDA Database Tracks Common Complications, Deaths

September 10, 2021

News Daily News

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review